PDS Biotechnology (PDSB) has entered into securities purchase agreements with new and existing healthcare focused institutional investors as ...

PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotech” or the “Company”), a late-stage immunotherapy company focused on transforming how the immune system targets and kills cancers, today ...

Sphere Fluidics today announced its rebranding to Sphere Bio. The name change marks a significant milestone in the Company’s ...